Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update

Idiopathic pulmonary fibrosis is a fatal form of progressive fibrosing interstitial pneumonia with limited treatment options. In recent years, its management has been transformed with the approval of two new antifibrotic drugs: nintedanib and pirfenidone. Nintedanib is a tyrosine kinase inhibitor th...

Descripción completa

Detalles Bibliográficos
Autor principal: Rodríguez-Portal, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833905/
https://www.ncbi.nlm.nih.gov/pubmed/29209910
http://dx.doi.org/10.1007/s40268-017-0221-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833905/
https://www.ncbi.nlm.nih.gov/pubmed/29209910
http://dx.doi.org/10.1007/s40268-017-0221-9

Ejemplares similares